Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

FDA approval for first CGP test for melanoma therapeutics

December 9, 2021 Business Services

The FDA has granted Foundation Medicine approval for its companion diagnostic, FoundationOne®CDx, for two groups of current and future FDA-approved …

EUA granted to AstraZeneca’s antibody therapy for COVID-19 prevention

December 9, 2021 Business Services

AstraZeneca announced that its Evusheld antibody combination for the prevention of COVID-19 in immunocompromised adults and adolescents has been granted …

QIAGEN announces CE marking of T-cell response measuring device

December 2, 2021 Business Services

QIAGEN has launched a CE-marked version of its QuantiFEROn SARS-CoV-2 assay, which measures T-cell responses to SARS-CoV-2, and aids in …

US government expands COVID-19 booster eligibility ahead of holidays

November 25, 2021 Business Services

The Biden administration has expanded COVID-19 booster eligibility, and millions of Americans have received their booster shots at a near …

Groundbreaking success shown in target drug combination for aggressive brain tumours

November 25, 2021 Business Services

A combination of two targeted cancer drugs have shown unprecedented activity in patients with highly malignant brain tumours carrying a …

Crohn’s patients see 65% remission in clinical trial

November 18, 2021 Business Services

Janssen has announced topline results from the Phase II GALAXI 1 clinical which showed rates of clinical remission previously reported …

NIAID and Children’s National Hospital begin long-term study of children with COVID-19

November 18, 2021 Business Services

The National Institutes of Health has commenced a long-term investigation into the impacts of COVID-19 in children. The study, supported …

AstraZeneca COVID-19 antibody drug offers 83% protection over six month period

November 18, 2021 Business Services

New data from AstraZeneca’s COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials have revealed high efficacy from a …

New experimental drug identified for pancreatic cancer treatment

November 11, 2021 Business Services

Professor Shudong Wang, Head of Drug Discovery and Development at the University of South Australia, is hoping to utilise the …

NICE recommends mogamulizumab for treatment of ultra-rare blood cancers

November 11, 2021 Business Services

NICE has recommended POTELIGEO (mogamulizumab), manufactured by Kyowa Kirin, as a treatment option for adults in England in Wales with …

Study shows cancer treatments could be repurposed as Alzheimer’s drugs

November 11, 2021 Business Services

A new study published in Science Advances has shared that cancer drugs can be repurposed as therapies to be tested …

New study confirms role of digital biomarkers in monitoring patients with multiple sclerosis

November 11, 2021 Business Services

Results from a clinical study, published by Ad Scientiam in â€˜Multiple Sclerosis and Related Disorders, secure the place of  MSCopilot Â® for the …

BIAL appoints Joerg Holenz as R&D General Manager

November 8, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …

England COVID-19 prevalence rose to highest levels in October, study finds

November 4, 2021 Business Services

Imperial College London have said that COVID-19 rates in England rose to its highest level on record in October. This …

WHO grants emergency use listing to COVID vaccine

November 4, 2021 Business Services

WHO has approved Bharat Biotech’s Covaxin COVID-19 vaccine for emergency use in individuals aged 18 years and above. Two doses …
The Gateway to Local Adoption Series

Latest content